5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine,
GW 2580,
GW-2580,
GW2580,
GW2580,
870483-87-7,
GW-2580,
cFMS Receptor Tyrosine Kinase Inhibitor,
GW 2580,
UNII-SRV0JCF9LI,
GW632580X,
SRV0JCF9LI,
CSF-1 Receptor Inhibitor,
5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine,
AK-43753,
5-{3-methoxy-4-[(4-methoxybenzyl)oxy]benzyl}pyrimidine-2,4-diamine,
5-[[3-methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]pyrimidine-2,4-diamine,
5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)-pyrimidine-2,4-diamine,
5-(3-METHOXY-4-(4-METHOXYBENZYLOXY)BENZYL)PYRIMIDINE-2,4-DIAMINE,
2,4-Pyrimidinediamine, 5-((3-methoxy-4-((4-methoxyphenyl)methoxy)phenyl)methyl)-,
5-[3-Methoxy-4-(4-methoxybenzyloxy)benzyl]pyrimidine-2,4-diamine,
5-[3-Methoxy-4-[(4-methoxybenzyl)oxy]benzyl]pyrimidine-2,4-diamine,
2,4-Pyrimidinediamine, 5-[[3-methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]-,
5-({3-methoxy-4-[(4-methoxyphenyl)methoxy]phenyl}methyl)pyrimidine-2,4-diamine,
Kinome_3757,
4at5,
CHEMBL261849,
GTPL5685,
SCHEMBL4326587,
BDBM32362,
CTK8E8759,
AOB6789,
DTXSID10236095,
EX-A579,
cid_11617559,
MYQAUKPBNJWPIE-UHFFFAOYSA-N,
HMS3229E11,
HMS3303G12,
HMS3305H21,
HMS3653B06,
BCP06918,
IN1333,
MFCD12024701,
s8042,
ZINC13985942,
AKOS022179064,
AM81255,
CCG-206754,
CS-3490,
GW 2380,
SB19390,
NCGC00242051-01,
4CA-0611,
AJ-64557,
HY-10917,
GW-2580 (GW2580),
RT-011987,
SC-203877,
FT-0700386,
G-255,
G0504,
SW212674-2,
Y0454,
A11959,
S-7799,
AB01092267-01,
[2-amino-5-(3-methoxy-4-p-anisyloxy-benzyl)pyrimidin-4-yl]amine,
5-[3-Methoxy-4-(4-methoxybenzyloxy)-benzyl]pyrimidine-2,4-diamine,
5-[[3-Methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]-2,4-pyrimidinediamine,
5-[[3-methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]pyrimidine-2,4-diamine.,
MUJ,
D0D6MH,
cc-705,
C20H22N4O3,
CID11617559,
A1655,